Incidence and economics of transvenous ICD lead complications: Implications for tricuspid valve function and interventions

Author:

Mason Pamela K.1,Schloss Edward J.2,Holbrook Reece3,Chiddarwar Tanvi3,Zhou Jiani3,Crossley George H.4ORCID

Affiliation:

1. Department of Medicine University of Virginia Charlottesville Virginia USA

2. Lindner Research Center The Christ Hospital Cincinnati Ohio USA

3. Medtronic, Inc. Mounds View Minnesota USA

4. Heart and Vascular Institute Vanderbilt University Nashville Tennessee USA

Abstract

AbstractBackgroundImplantable cardioverter‐defibrillators are used globally and are reliable, but complications related to transvenous leads remain a concern. Evidence related to the incidence and costs of those complications is heterogeneous with respect to scope and healthcare system. This analysis aims to create estimates of the incidence and costs of tricuspid valve (TV) complications, lead failures, and lead extractions from a single large real‐world data set.Methods and ResultsThis retrospective longitudinal cohort study used the deidentified Medicare Fee for Service administrative claims database. A total of 116 036 patients with de novo transvenous ICD implant were analyzed. Mean hospital costs were $26 903 for tricuspid valve complications, $20 851 for lead failures, and $22 278 for lead extractions.ConclusionsTransvenous ICD lead complications incur significant costs to patients, hospitals, and payers when they occur. Advancements in lead technology that reduce these complications could bring significant clinical and economic value.

Funder

Medtronic

Publisher

Wiley

Reference4 articles.

1. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society;Al‐Khatib SM;Circulation,2017

2. The Implantable Cardioverter-Defibrillator Lead: Principles, Progress, and Promises

3. Transcatheter Tricuspid Valve Replacement With the EVOQUE System

4. Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3